The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing brief, focused symptom assessment in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): The FHNSI-10.
 
Sara Shaunfield
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Foamix (Inst); Ipsen (Inst); PledPharma (Inst)
 
Susan Yount
Research Funding - Alexion Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Ipsen (Inst); Trevena (Inst)
 
Lara Boyken
Research Funding - Bayer (Inst); Daiichi Sankyo (Inst)
 
Boyka Stoykova
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Merck; Pfizer; Roche
 
Mark Agulnik
Consulting or Advisory Role - Eisai; Janssen; Lilly; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Janssen
 
Sandeep Samant
Stock and Other Ownership Interests - Y-Trap Inc.
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; PledPharma; Puma Biotechnology
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen